Travere Therapeutics, Inc. (TVTX)

Every official Travere Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Travere Therapeutics, Inc. documents

• Travere Therapeutics, Inc. 10-K 2026TVTX 10-K 2026: annual report for fiscal 2026
• Travere Therapeutics, Inc. 10-K 2025TVTX 10-K 2025: annual report for fiscal 2025
• Travere Therapeutics, Inc. 10-K 2024TVTX 10-K 2024: annual report for fiscal 2024
• Travere Therapeutics, Inc. 10-K 2023TVTX 10-K 2023: annual report for fiscal 2023
• Travere Therapeutics, Inc. 10-K 2022TVTX 10-K 2022: annual report for fiscal 2022
• Travere Therapeutics, Inc. 10-Q 2026TVTX 10-Q 2026: quarterly report for fiscal 2026
• Travere Therapeutics, Inc. 10-Q 2025TVTX 10-Q 2025: quarterly report for fiscal 2025
• Travere Therapeutics, Inc. 10-Q 2024TVTX 10-Q 2024: quarterly report for fiscal 2024
• Travere Therapeutics, Inc. 10-Q 2023TVTX 10-Q 2023: quarterly report for fiscal 2023
• Travere Therapeutics, Inc. 10-Q 2022TVTX 10-Q 2022: quarterly report for fiscal 2022
• Travere Therapeutics, Inc. 8-K 2026TVTX 8-K 2026: current report for fiscal 2026
• Travere Therapeutics, Inc. 8-K 2025TVTX 8-K 2025: current report for fiscal 2025
• Travere Therapeutics, Inc. 8-K 2024TVTX 8-K 2024: current report for fiscal 2024
• Travere Therapeutics, Inc. 8-K 2023TVTX 8-K 2023: current report for fiscal 2023
• Travere Therapeutics, Inc. 8-K 2022TVTX 8-K 2022: current report for fiscal 2022
• Travere Therapeutics, Inc. DEF 14A 2026TVTX DEF 14A 2026: proxy statement for fiscal 2026
• Travere Therapeutics, Inc. DEF 14A 2025TVTX DEF 14A 2025: proxy statement for fiscal 2025
• Travere Therapeutics, Inc. DEF 14A 2024TVTX DEF 14A 2024: proxy statement for fiscal 2024
• Travere Therapeutics, Inc. DEF 14A 2023TVTX DEF 14A 2023: proxy statement for fiscal 2023
• Travere Therapeutics, Inc. DEF 14A 2022TVTX DEF 14A 2022: proxy statement for fiscal 2022
• Travere Therapeutics, Inc. Form 4 2026TVTX Form 4 2026: insider trading filing for fiscal 2026
• Travere Therapeutics, Inc. Form 4 2025TVTX Form 4 2025: insider trading filing for fiscal 2025
• Travere Therapeutics, Inc. Form 4 2024TVTX Form 4 2024: insider trading filing for fiscal 2024
• Travere Therapeutics, Inc. Form 4 2023TVTX Form 4 2023: insider trading filing for fiscal 2023
• Travere Therapeutics, Inc. Form 4 2022TVTX Form 4 2022: insider trading filing for fiscal 2022
• Travere Therapeutics, Inc. S-1 2026TVTX S-1 2026: registration statement for fiscal 2026
• Travere Therapeutics, Inc. S-1 2025TVTX S-1 2025: registration statement for fiscal 2025
• Travere Therapeutics, Inc. S-1 2024TVTX S-1 2024: registration statement for fiscal 2024
• Travere Therapeutics, Inc. S-1 2023TVTX S-1 2023: registration statement for fiscal 2023
• Travere Therapeutics, Inc. S-1 2022TVTX S-1 2022: registration statement for fiscal 2022
• Travere Therapeutics, Inc. 13F 2026TVTX 13F 2026: institutional holdings for fiscal 2026
• Travere Therapeutics, Inc. 13F 2025TVTX 13F 2025: institutional holdings for fiscal 2025
• Travere Therapeutics, Inc. 13F 2024TVTX 13F 2024: institutional holdings for fiscal 2024
• Travere Therapeutics, Inc. 13F 2023TVTX 13F 2023: institutional holdings for fiscal 2023
• Travere Therapeutics, Inc. 13F 2022TVTX 13F 2022: institutional holdings for fiscal 2022

More companies